These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 22455335)
1. Genetic polymorphisms in MMP 2, 9 and 3 genes modify lung cancer risk and survival. González-Arriaga P; Pascual T; García-Alvarez A; Fernández-Somoano A; López-Cima MF; Tardón A BMC Cancer; 2012 Mar; 12():121. PubMed ID: 22455335 [TBL] [Abstract][Full Text] [Related]
2. Current evidence on the relationship between five polymorphisms in the matrix metalloproteinases (MMP) gene and lung cancer risk: a meta-analysis. Hu C; Wang J; Xu Y; Li X; Chen H; Bunjhoo H; Xiong W; Xu Y; Zhao J Gene; 2013 Mar; 517(1):65-71. PubMed ID: 23313298 [TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of MMP2, MMP3, and MMP9 promoter polymorphisms and head and neck cancer risk. Zhang C; Li C; Zhu M; Zhang Q; Xie Z; Niu G; Song X; Jin L; Li G; Zheng H PLoS One; 2013; 8(4):e62023. PubMed ID: 23637955 [TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinases 1, 2, 3 and 9 functional single-nucleotide polymorphisms in idiopathic recurrent spontaneous abortion. Pereza N; Ostojić S; Volk M; Kapović M; Peterlin B Reprod Biomed Online; 2012 May; 24(5):567-75. PubMed ID: 22406112 [TBL] [Abstract][Full Text] [Related]
6. [Correlation of matrix metalloproteinase-3 polymorphism to genetic susceptibility and lymph node metastasis of non-small cell lung cancer]. Fang SM; Jin X; Li Y; Wang R; Guo W; Wang N; Zhang JH Ai Zheng; 2005 Mar; 24(3):305-10. PubMed ID: 15757531 [TBL] [Abstract][Full Text] [Related]
7. Putative functional polymorphisms of MMP9 predict survival of NSCLC in a Chinese population. Jin G; Miao R; Hu Z; Xu L; Huang X; Chen Y; Tian T; Wei Q; Boffetta P; Shen H Int J Cancer; 2009 May; 124(9):2172-8. PubMed ID: 19132754 [TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China. Fang S; Jin X; Wang R; Li Y; Guo W; Wang N; Wang Y; Wen D; Wei L; Zhang J Carcinogenesis; 2005 Feb; 26(2):481-6. PubMed ID: 15528217 [TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms in MMP 2, 3, 7, and 9 genes and the susceptibility and clinical outcome of cervical cancer in a Chinese Han population. Xie B; Zhang Z; Wang H; Chen Z; Wang Y; Liang H; Yang G; Yang X; Zhang H Tumour Biol; 2016 Apr; 37(4):4883-8. PubMed ID: 26526578 [TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase variants associated with risk and clinical outcome of esophageal cancer. Zhang L; Xi RX; Zhang XZ Genet Mol Res; 2015 May; 14(2):4616-24. PubMed ID: 25966235 [TBL] [Abstract][Full Text] [Related]
11. Association of MMP9-1562C/T and MMP13-77A/G Polymorphisms with Non-Small Cell Lung Cancer in Southern Chinese Population. Li W; Jia MX; Wang JH; Lu JL; Deng J; Tang JX; Liu C Biomolecules; 2019 Mar; 9(3):. PubMed ID: 30889876 [TBL] [Abstract][Full Text] [Related]
12. [Associating of polymorphism in the promoter regions of genes of metalloproteinase (MMP2, MMP3, MMP9) with options of the clinical course of breast cancer in Russian women]. Shevchenko AV; Konenkov VI; Garbukov EIu; Stakheeva MN Vopr Onkol; 2014; 60(5):630-5. PubMed ID: 25816670 [TBL] [Abstract][Full Text] [Related]
13. Variations in matrix metalloproteinase-1, -3, and -9 genes and the risk of acute coronary syndrome and coronary artery disease in the Chinese Han population. Xu X; Wang L; Xu C; Zhang P; Yong F; Liu H; Wang J; Shi Y Coron Artery Dis; 2013 Jun; 24(4):259-65. PubMed ID: 23377317 [TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase (MMP) -2, -7 and -9 promoter polymorphisms in colorectal cancer in ethnic Kashmiri population - A case-control study and a mini review. Banday MZ; Sameer AS; Mir AH; Mokhdomi TA; Chowdri NA; Haq E Gene; 2016 Sep; 589(1):81-89. PubMed ID: 27222481 [TBL] [Abstract][Full Text] [Related]
16. Functional polymorphisms in the promoter regions of MMP2 and MMP3 are not associated with melanoma progression. Cotignola J; Roy P; Patel A; Ishill N; Shah S; Houghton A; Coit D; Halpern A; Busam K; Berwick M; Orlow I J Negat Results Biomed; 2007 Oct; 6():9. PubMed ID: 17958893 [TBL] [Abstract][Full Text] [Related]
17. Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer. Rollin J; Régina S; Vourc'h P; Iochmann S; Bléchet C; Reverdiau P; Gruel Y Lung Cancer; 2007 May; 56(2):273-80. PubMed ID: 17208328 [TBL] [Abstract][Full Text] [Related]
18. MMP2 gene-735 C/T and MMP9 gene -1562 C/T polymorphisms in JAK2V617F positive myeloproliferative disorders. Sag SO; Gorukmez O; Ture M; Gorukmez O; Topak A; Sahinturk S; Ocakoglu G; Gulten T; Ali R; Yakut T Asian Pac J Cancer Prev; 2015; 16(2):443-9. PubMed ID: 25684469 [TBL] [Abstract][Full Text] [Related]